Estrogen receptor inhibits interleukin-6 gene expression by disruption of nuclear factor kappaB transactivation (Q24309665)

Circulating levels of cytokines that modulate bone resorption: effects of age and menopause in women

GOA release 2020-03-11

1 reference

Hui Liu

1

0 references

Kenian Liu

series ordinal

2

0 references

Donald L Bodenner

series ordinal

3

0 references

language of work or name

English

0 references

publication date

21 August 2005

0 references

published in

Cytokine

0 references

volume

31

0 references

issue

4

0 references

page(s)

251-7

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2004.12.008

7 January 2021

Phytoestrogen genistein acts as an estrogen agonist on human osteoblastic cells through estrogen receptors alpha and beta

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2004.12.008

7 January 2021

Inactivation of NF-kappa B inhibitor I kappa B alpha: ubiquitin-dependent proteolysis and its degradation product

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2004.12.008

7 January 2021

17 beta-estradiol inhibits tumor necrosis factor-alpha-induced nuclear factor-kappa B activation by increasing nuclear factor-kappa B p105 level in MCF-7 breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2004.12.008

7 January 2021

Interleukin-6 and viral myocarditis: the Yin-Yang of cardiac innate immune responses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2004.12.008

7 January 2021

The nuclear receptor superfamily: the second decade

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2004.12.008

7 January 2021

Steroid and related receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2004.12.008

7 January 2021

Repression of interleukin-6 gene expression by 17 beta-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2004.12.008

7 January 2021

Interleukin-6 inhibits bone formation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2004.12.008

7 January 2021

Genetics of interleukin 6: implications for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2004.12.008

7 January 2021

Suppression by estrogen receptor beta of AP-1 mediated transactivation through estrogen receptor alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2004.12.008

7 January 2021

17beta-Estradiol inhibits cytokine induction of the human E-selectin promoter

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2004.12.008

7 January 2021

IL-6 in autoimmune disease and chronic inflammatory proliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2004.12.008

7 January 2021

Interleukin-6 modulates trabecular and endochondral bone turnover in the nude mouse by stimulating osteoclast differentiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2004.12.008

7 January 2021

Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2004.12.008

7 January 2021

Negative interaction between the RelA(p65) subunit of NF-kappaB and the progesterone receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2004.12.008

7 January 2021

Distinct domains of the RelA NF-kappaB subunit are required for negative cross-talk and direct interaction with the glucocorticoid receptor.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2004.12.008

7 January 2021

Mutations in the estrogen receptor ligand binding domain discriminate between hormone-dependent transactivation and transrepression

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2004.12.008

7 January 2021

Mechanism of kappa B DNA binding by Rel/NF-kappa B dimers

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2004.12.008

7 January 2021

Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2004.12.008

7 January 2021

Characterization of the physical interaction between estrogen receptor alpha and JUN proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2004.12.008

7 January 2021

Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2004.12.008

7 January 2021

Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2004.12.008

7 January 2021

Molecular pathways of steroid receptor action

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2004.12.008

7 January 2021

Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2004.12.008

7 January 2021

Increased osteoclast development after estrogen loss: mediation by interleukin-6

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2004.12.008

7 January 2021

Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2004.12.008

7 January 2021

Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2004.12.008

7 January 2021

Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2004.12.008

7 January 2021

AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2004.12.008

7 January 2021

Molecular determinants of the estrogen receptor-coactivator interface

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2004.12.008

7 January 2021

The NF-kappa B and I kappa B proteins: new discoveries and insights

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2004.12.008

7 January 2021

Competition for p300 regulates transcription by estrogen receptors and nuclear factor-kappaB in human coronary smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2004.12.008

7 January 2021

17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2004.12.008

7 January 2021

Transcriptional activities of estrogen and glucocorticoid receptors are functionally integrated at the AP-1 response element

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2004.12.008

7 January 2021

An activator protein 1-like motif mediates 17beta-estradiol repression of gonadotropin-releasing hormone receptor promoter via an estrogen receptor alpha-dependent mechanism in ovarian and breast cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2004.12.008

7 January 2021

Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2004.12.008

7 January 2021

Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells: comparison of the effects of 17-beta oestradiol and raloxifene

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2004.12.008

7 January 2021

Anti-interleukin-6 therapy for Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2004.12.008

7 January 2021